Due to health issues, this site is no longer maintained and will be shut down shortly. |
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases.
$13.07 -2.17 (-14.22%)
As of 03/27/2023 14:20:22 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.